Growing community of inventors

Boston, MA, United States of America

Lori K Taylor

Average Co-Inventor Count = 6.23

ph-index = 8

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 110

Lori K TaylorRebecca S Hoffman (11 patents)Lori K TaylorElliot Keith Chartash (11 patents)Lori K TaylorGeorge Richard Granneman (11 patents)Lori K TaylorPhilip Yan (11 patents)Lori K TaylorMark Weinberg (5 patents)Lori K TaylorJochen G Salfeld (3 patents)Lori K TaylorSubhashis Banerjee (3 patents)Lori K TaylorSteven Alan Fischkoff (3 patents)Lori K TaylorDaniel Edward Tracey (3 patents)Lori K TaylorAnwar Murtaza (3 patents)Lori K TaylorWilliam T Barchuk (3 patents)Lori K TaylorClive E Spiegler (3 patents)Lori K TaylorElliot Chartash (0 patent)Lori K TaylorSteven Fischkoff (0 patent)Lori K TaylorEliot Keith Chartash (0 patent)Lori K TaylorClive E Spiegler (0 patent)Lori K TaylorLori K Taylor (11 patents)Rebecca S HoffmanRebecca S Hoffman (16 patents)Elliot Keith ChartashElliot Keith Chartash (14 patents)George Richard GrannemanGeorge Richard Granneman (12 patents)Philip YanPhilip Yan (11 patents)Mark WeinbergMark Weinberg (21 patents)Jochen G SalfeldJochen G Salfeld (33 patents)Subhashis BanerjeeSubhashis Banerjee (14 patents)Steven Alan FischkoffSteven Alan Fischkoff (14 patents)Daniel Edward TraceyDaniel Edward Tracey (10 patents)Anwar MurtazaAnwar Murtaza (8 patents)William T BarchukWilliam T Barchuk (6 patents)Clive E SpieglerClive E Spiegler (3 patents)Elliot ChartashElliot Chartash (0 patent)Steven FischkoffSteven Fischkoff (0 patent)Eliot Keith ChartashEliot Keith Chartash (0 patent)Clive E SpieglerClive E Spiegler (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Abbvie Biotechnology Ltd (11 from 93 patents)


11 patents:

1. 9512216 - Use of TNFα inhibitor

2. 9499615 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

3. 9187559 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

4. 9090689 - Use of TNFα inhibitor for treatment of psoriasis

5. 9085620 - Use of TNFα inhibitor for treatment of psoriatic arthritis

6. 9061005 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

7. 8986693 - Use of TNFα inhibitor for treatment of psoriasis

8. 8961973 - Multiple-variable dose regimen for treating TNFα-related disorders

9. 8961974 - Multiple-variable dose regimen for treating TNFα-related disorders

10. 8906373 - Use of TNF-alpha inhibitor for treatment of psoriasis

11. 8889136 - Multiple-variable dose regimen for treating TNFα-related disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…